And the results of external validation using GEPIA suggested that HSPB1 PIP5K1C and PRKCA expressed highly in normal tissue and lowly in PRAD, APP expressed lowly in normal thyroid and highly in PRAD (Figure S3). This evidence concerns the gene PRKCA and prostate adenocarcinoma.